Transmembrane Proteases As Disease Markers and Targets for Therapy
Overview
Biology
Authors
Affiliations
Transmembrane proteases (i.e. membrane-associated proteases, ectoproteases) are present in a wide variety of tissues and cell types including endothelial, epithelial and hematopoietic cells. Natural and synthetic inhibitors have been characterized and have revealed that certain ectoenzymes are able to modulate bioactive peptide responses and to influence major biological events such as cell proliferation, survival and invasiveness. Dysregulated expression of some of them in human diseases triggers research on their role in pathophysiology, on their value as disease markers and as putative targets for therapy.
Design, Synthesis, and Biological Evaluation of APN and AKT Dual-Target Inhibitors.
Liu Q, Dong H, Zhao W, Zhang G, Li S, Xu Q ACS Med Chem Lett. 2021; 12(12):1932-1941.
PMID: 34917257 PMC: 8667313. DOI: 10.1021/acsmedchemlett.1c00504.
Al-Mansoori L, Bashraheel S, Al Qahtani A, OConnor C, Elsinga P, Goda S Oncotarget. 2020; 11(6):619-633.
PMID: 32110281 PMC: 7021235. DOI: 10.18632/oncotarget.27478.
Chuang H, Jiang J, Yang M, Wang H, Li M, Tsai C Oncotarget. 2017; 8(13):21266-21280.
PMID: 28177885 PMC: 5400582. DOI: 10.18632/oncotarget.15072.
Liu Y, Tu G, Lai X, Kuang B, Li S J Mol Model. 2016; 22(10):236.
PMID: 27624165 DOI: 10.1007/s00894-016-3105-y.
Bouchet S, Tang R, Fava F, Legrand O, Bauvois B Oncotarget. 2014; 5(18):8211-22.
PMID: 25246708 PMC: 4226678. DOI: 10.18632/oncotarget.1788.